|
|
|
|
Дата |
|---|
| 12.10.2026 |
| 09.10.2026 |
| 08.10.2026 |
| 07.10.2026 |
| 06.10.2026 |
| 05.10.2026 |
| 02.10.2026 |
| 01.10.2026 |
| 30.09.2026 |
| 29.09.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
232.00
|
228.00
|
232.00
|
232.00
|
|
|
1 221 324.50
|
|
|
|
|
231.50
|
230.50
|
232.00
|
232.00
|
|
|
1 323 390.00
|
|
|
|
|
231.00
|
227.50
|
232.00
|
232.00
|
|
|
1 376 046.50
|
|
|
|
|
229.50
|
227.00
|
231.00
|
231.00
|
|
|
1 036 053.50
|
|
|
|
|
228.50
|
226.00
|
230.50
|
230.50
|
|
|
1 078 886.25
|
|
|
|
|
231.50
|
228.50
|
234.00
|
228.50
|
|
|
1 437 089.50
|
|
|
|
|
230.00
|
228.00
|
233.00
|
231.50
|
|
|
987 859.50
|
|
|
|
|
233.50
|
232.00
|
235.50
|
233.50
|
|
|
1 090 814.75
|
|
|
|
|
232.50
|
232.00
|
235.00
|
233.50
|
|
|
746 775.50
|
|
|
|
|
230.00
|
230.00
|
233.50
|
232.00
|
|
|
550 720.50
|
|
Период |
|---|
| 2025, регулярные |
| 2024, регулярные |
| 2023, регулярные |
| 2022, регулярные |
| 2021, регулярные |
| 2021, регулярные |
| 2020, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2018, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
17.06.2026
|
18.06.2026 |
9 CHF |
|
02.07.2025
|
03.07.2025 |
4.9 CHF |
|
07.08.2024
|
08.08.2024 |
7.5 CHF |
|
03.08.2023
|
04.08.2023 |
7.5 CHF |
|
30.08.2022
|
31.08.2022 |
9.7 CHF |
|
07.09.2021
|
08.09.2021 |
12.5 CHF |
|
08.09.2020
|
09.09.2020 |
7.7 CHF |
|
10.09.2019
|
11.09.2019 |
7.5 CHF |
|
19.09.2018
|
20.09.2018 |
1.5 CHF |
|
27.06.2018
|
28.06.2018 |
5.5 CHF |
HBM Healthcare Investments actively invests in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas. The company holds and manages an international portfolio of some twenty five promising companies. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided on their strategic directions. This is what makes HBM Healthcare Investments an interesting alternative to investing in big pharma and biotech companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN).
